- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02436369
The Effect of Yogurt Enriched With Flaxseed on Cardiovascular Risk Factors in Type 2 Diabetic Patients
May 3, 2015 updated by: Urmia University of Medical Sciences
The Effect of Yogurt Enriched With Flaxseed on Cardiovascular Risk Factors in Type 2 Diabetic
The investigators aimed to add flaxseed with high content of n-3 polyunsaturated fatty acids to low fat yogurt to obtain beneficial without adverse effects of it.
In this parallel randomized controlled trial the investigators recruited 70 diabetic patients and randomly allocated to control and treatment groups.
Participants in treatment group consumed 30 gr flaxseed in 200 gr low fat yogurt, while controls consumed 200 gr just low fat yogurt daily.
Lipid profile, fasting blood sugar, glycosylated hemoglobin, systolic and diastolic blood pressure, weight, waist circumference and body mass index were measured at the first and end of the trial.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Nutritionists have concern about consumption of full fat dairy in diabetic patients due to their content of saturated fatty acids.
The investigators aimed to add flaxseed with high content of n-3 polyunsaturated fatty acids to low fat yogurt to obtain beneficial without adverse effects of it.
In this parallel randomized controlled trial the investigators recruited 70 diabetic patients and randomly allocated to control and treatment groups.
Participants in treatment group consumed 30 gr flaxseed in 200 gr low fat yogurt, while controls consumed 200 gr just low fat yogurt daily.
Lipid profile, fasting blood sugar, glycosylated hemoglobin, systolic and diastolic blood pressure, weight, waist circumference and body mass index were measured at the first and end of the trial.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI between 20 and 35 kg/m2 -
- treated with oral hypoglycemic agents (Metformin or Glibenclamide)
- no use of insulin
- fasting blood glucose≥ 126 (but less than 400 mg/dl)or 2 hours blood sugar ≤ 200 mg/dl
- no pregnancy and lactation
- Blood lipids and blood pressure-lowering agents must remained unalteredwithin the last 3 months.
Exclusion Criteria:
- Participants were excluded if they smoked, used alcohol, took dietary supplements containing Omega 3, phytoestrogens, antioxidants and fiber regularly, had been diagnosed with GI disease or renal, liver, cancer , inflammatory disease, had food allergies or intolerances
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: low fat yogurt enriched with flaxseed
200 gr low fat yogurt enriched with 30 gr flaxseed
|
daily intake of low fat yogurt enriched with flaxseed for 8 weeks
|
Placebo Comparator: low fat yogurt
200 gr low fat yogurt
|
daily intake of low fat yogurt for 8 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in values of FBS at 8 week
Time Frame: 8 weeks
|
FBS: Fasting blood sugar
|
8 weeks
|
Change from baseline in values of HbA1c at 8 week
Time Frame: 8 weeks
|
HbA1C: glycosylated hemoglobin
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in values of weight at 8 week
Time Frame: 8 weeks
|
8 weeks
|
|
Change from baseline in values of waist circumference at 8 week
Time Frame: 8 weeks
|
8 weeks
|
|
Change from baseline in values of body mass index at 8 week
Time Frame: 8 weeks
|
8 weeks
|
|
Change from baseline in values of blood pressure at 8 week
Time Frame: 8 weeks
|
Blood pressure: systolic blood pressure, diastolic blood pressure
|
8 weeks
|
Change from baseline in values of Lipid profile (Total cholesterol, triglyceride, LDL-C, HDL-C) at 8 week
Time Frame: 8 weeks
|
Lipid profile:Total cholesterol, triglyceride, LDL-C, HDL-C
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
November 1, 2014
Study Completion (Actual)
January 1, 2015
Study Registration Dates
First Submitted
April 19, 2015
First Submitted That Met QC Criteria
May 3, 2015
First Posted (Estimate)
May 6, 2015
Study Record Updates
Last Update Posted (Estimate)
May 6, 2015
Last Update Submitted That Met QC Criteria
May 3, 2015
Last Verified
April 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- umsu.rec.1393.3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on low fat yogurt enriched with flaxseed
-
Clinical Nutrition Research Center, Illinois Institute...Hass Avocado BoardActive, not recruiting
-
University of ThessalyCompletedInflammation | Oxidative StressGreece
-
Maastricht University Medical CenterCompleted
-
ANTONIOS KOUTELIDAKISDemocritus University of Thrace; University of IoanninaEnrolling by invitation
-
King Edward Medical UniversityUnknownLipodystrophy | Craniofacial Microsomia | Mixed Connective Tissue Disease | Romberg's Disease
-
Hospices Civils de LyonCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche... and other collaboratorsRecruiting
-
Temple UniversityAlmond Board of CaliforniaCompletedHypertension | Obesity | Hyperlipidemia | Metabolic Syndrome XUnited States
-
Ryerson UniversityNational Dairy Council; Dairy Management Inc.Recruiting
-
The University of Hong KongCompleted
-
Danone JapanCompletedNormal and Mild Hypercholesterolemic SubjectsJapan